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Discriminant analysisBehavioral indicators in the murine Bacille Calmette Guérin (BCG) model of inﬂammation have been
studied individually; however, the variability of the behaviors across BCG levels and the mouse-to-mouse
variation within BCG-treatment group are only partially understood. The objectives of this study were:
(1) to gain a comprehensive understanding of sickness and depression-like behaviors in a BCG model
of inﬂammation using multivariate approaches, and (2) to explore behavioral differences between
BCG-treatment groups and among mice within group. Adult mice were challenged with either 0 mg (sal-
ine), 5 mg or 10 mg of BCG (BCG-treatment groups: BCG0, BCG5, or BCG10, respectively) at Day 0 of the
experiment. Sickness indicators included body weight changes between Day 0 and Day 2 and between
Day 2 and Day 5, and horizontal locomotor activity and vertical activity (rearing) measured at Day 6.
Depression-like indicators included duration of immobility in the forced swim test and in the tail suspen-
sion test at Day 6 and sucrose consumption in the sucrose preference test at Day 7. The simultaneous
consideration of complementary sickness and depression-like indicators enabled a more precise
characterization of behavioral changes associated with BCG-treatment and of mouse-to-mouse variation,
relative to the analysis of indicators individually. Univariate and multivariate analyses conﬁrmed differ-
ences between BCG-treatment groups in weight change early on the trial. Signiﬁcant differences between
BCG-treatment groups in depression-like behaviors were still measurable after Day 5. The potential for
multivariate models to account for the correlation between behavioral indicators and to augment the
analytical precision relative to univariate models was demonstrated both for sickness and for depres-
sion-like indicators. Unsupervised learning approaches revealed the complementary information pro-
vided by the sickness and depression-like indicators considered. Supervised learning approaches using
cross-validation conﬁrmed subtle differences between BCG-treatment groups and among mice within
group identiﬁed by the consideration of sickness and depression-like indicators. These ﬁndings support
the recommendation for multivariate and multidimensional analyses of sickness and depression-like
indicators to augment the systemic understanding of the behavioral changes associated with infection.
 2014 The Authors. Published by Elsevier Inc. This is anopenaccess article under theCCBY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
The relationship between inﬂammation and depression in
humans and in animal models is well-established. Individuals
receiving immunotherapies have a higher incidence of depressivesymptoms (Capuron and Miller, 2011). Patients with major depres-
sive disorders have higher levels of serum pro-inﬂammatory cyto-
kines than healthy controls (Maes, 2011). Likewise, depressive
phenotypes were observed in response to bacterial challenge
(Brydon et al., 2008). These associations suggested that inﬂamma-
tion may result in depressive symptomatology mediated by neuro-
immune mechanisms. Designed experiments using animal models
are offering insights into the relationship between infection,
inﬂammation, and depression-like indicators. Mice injected live
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tory pro-inﬂammatory cytokines and indoleamine 2,3-dioxygenase
activity. These mice exhibited sickness behaviors encompassing
reduction in body weight and locomotor activity from Day 5 to
Day 7. Likewise, challenged mice demonstrated depressive-like
behaviors including lower mobility in the tail suspension test
and in the Porsolt forced swim test, and lower sucrose intake in
the sucrose preference test from Day 7 to Day 30 after treatment
(Moreau et al., 2008; O’Connor et al., 2009). In addition, substantial
mouse-to-mouse variation in response to BCG treatment was
reported, including up to 30% of treated mice failing to exhibit
adverse mobility effects (Platt et al., 2013).
Reductionist approaches based on the analysis of individual
components have dominated the study of complex behavioral
responses to infection. However, these reductionist approaches
could have hindered the identiﬁcation and characterization of sys-
temic responses across multiple and typically correlated behaviors.
Six studies reported associations between BCG-treatment and
sickness and depression-like behaviors in mice (Moreau et al.,
2008; O’Connor et al., 2009; Kelley et al., 2013; Painsipp et al.,
2013; Platt et al., 2013; Vijaya Kumar et al., 2014). In these studies,
behavioral indicators were analyzed separately. This univariate
approach could lead to substantially lower precision to detect
differences between treatment groups, especially when the number
of mice per group is low. Consideration of the covariation between
indicators through multivariate approaches could enhance the pre-
cision to characterize smaller differences between treatment
groups and the statistical signiﬁcance of the BCG-treatment effect.
Furthermore, the consideration of multiple indicators simulta-
neously could enhance the characterization of mouse-to-mouse
variation and strengthen the identiﬁcation of behavioral outliers.
However, higher precision could come at the expense of higher
number of parameters that need to be speciﬁed or estimated.
Whether this trade-off results in a net beneﬁt of better under-
standing the relationship between infection and sickness and
depression indicators needs to be investigated.
The objectives of this study were: (1) to gain a comprehensive
characterization of behavioral indicators in the BCG model of
inﬂammation using multivariate approaches, and (2) to uncover
behavioral differences associated with BCG-treatment level.
Supporting activities include the consideration of complementary
multidimensional approaches and study of mouse-to-mouse
variation.2. Materials and methods
2.1. Samples
Adult (12–14 weeks old) male C57BL/6J mice from the Charles
River Laboratory were studied. Mice were housed in individual
cages under a normal 12:12 h light/dark cycle in a temperature-
(23 C) and humidity- (45%) controlled room. Mice were offered
water and food ad libitum (Teklad 8640 chow, Harlan Laboratories,
Indianapolis, IN, USA) and handled daily for one week prior to the
trial to ensure adaptation. Within the light cycle (lights on
10:00 PM–10:00 AM), behavioral tests began during the start of
the dark phase under red lighting (O’Connor et al., 2009).
Three doses of the BCG strain ofMycobacterium boviswere stud-
ied. Live attenuated mycobacteria TICE BCG (50 mg wet weight of
lyophilized culture containing 1  108 colony forming units or
CFU/vial) was used (Organon USA Inc., USA). Vial reconstitution
prior to inoculation used preservative-free saline and followed
the provider’s instructions. Individual mice were challenged once
with either 10 mg/mouse (BCG10 group, n = 5), 5 mg/mouse
(BCG5 group, n = 6) or sterile saline solution (BCG0 group, n = 7)at Day 0 of the experiment. Treatments were standardized to
0.3 ml/mouse and administered via intraperitoneal injection. Each
mice was measured for the same set of sickness and depression-
like indicators and thus, the measurements from 18 mice (5 mice
BCG10 + 6 mice BCG5 + 7 mice BCG0) were analyzed. Experiments
and measurements were implemented in accordance with the
Animal Care and Use Program established by the University of
Illinois at Urbana-Champaign Institutional Animal Care and Use
Committee.
2.2. Sickness and depression-like indicators
The behavioral measurements are described in the sequence
they were obtained. The measurements started early on the dark
phase of the light cycle and behavioral experiments were per-
formed during the ﬁrst 7 h of the dark phase of the light cycle
and followed established protocols (O’Connor et al., 2009;
Lawson et al., 2013). Body weight changes following the BCG chal-
lenge was one indicator of sickness. Changes in body weight
between Day 0 and Day 5 reﬂected the impact of infection on sick-
ness through anorexia and modiﬁcations to metabolic homeosta-
sis. Recovery from sickness was inferred from the subsequent
increase in weight and similarity in locomotor activity and rearing
between BCG treated and untreated mice at Day 6. Body weight
was the ﬁrst measurement and was recorded early in the dark
phase of the light cycle. Daily measurements started on Day 1
to record the baseline weight. Locomotor activity measurements
reﬂected the complementary impact of infection on sickness
through fatigue and apathy for exploration. Horizontal movements
(termed locomotor activity) and vertical locomotor activity
(termed rearing) were measured at Day 6 in a novel cage using
an established protocol for the open ﬁeld method (O’Connor
et al., 2009). Brieﬂy, individual mice were placed in a standard
acrylic cage including opaque walls and an insert dividing the ﬂoor
into quadrants. The movements of the mice during 5 min were
video recorded and counted by a trained observer that was blind
to the treatment assignments. Locomotor activity was measured
as the number of times the mouse crossed one of the grid lines
with all four paws and rearing was measured as the number of
times the mice stood on their hind legs either along a wall or inde-
pendently (Brown et al., 1999).
Complementary depression-like indicators that reﬂect despair-
and reward-based behaviors were measured. The duration of
immobility in the tail suspension test and in the forced swim test
at Day 6 were used as indicators of despair-based behaviors
(Castagné et al., 2011). Sucrose intake in the sucrose preference
test at Day 7 was used as indicator of anhedonia and a reward-
based behavior (Strekalova et al., 2011).
The forced swim test followed the locomotor activity test
(O’Connor et al., 2009). In the forced swim test, mice were placed
in a cylinder containing 15-cm-high water that is approximately
23 C. After placing the mice in the water, the activity was recorded
for 6 min. The duration of immobility was measured during the
ﬁnal 5 min by a trained observer (O’Connor et al., 2009). Applying
published protocols, the tail suspension test followed the forced
swim test (O’Connor et al., 2009). Mice were suspended by their
tails from a hanger linked to a load cell for 10 min. The force trans-
ducer detected movements and the seconds spent motionless or
immobile per minute were automatically recorded using the
Mouse Tail Suspension package (MED-TSS-MS; Med Associates
Inc., St. Albans, VT, USA). The average time that a mouse remained
motionless per minute between 3 and 8 min post suspension was
used as an indicator of immobility to remove extreme behaviors
at the start and end of the trial. The spacing between the sickness
locomotor and depression despair measurements within a mouse
was on average 2.4 h. The sucrose preference test was
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et al. (2013). Mice had access to water and a 1% (wt/vol) sucrose
solution, each available from a separate bottle. On Day 2 prior
to treatment, mice were trained by simultaneous presentation
with a bottle of water and a bottle of 1% (wt/vol) sucrose solution.
Consumption of water and sucrose was measured by weighing the
bottles after a 24-h period. Sucrose preference was measured as
the sucrose consumed relative to the total water and sucrose con-
sumed, expressed as percentage.3. Statistical analysis
A comprehensive analysis of the changes in behavior associated
with BCG challenge was undertaken using complementary univar-
iate and multivariate approaches including linear models, unsuper-
vised and supervised learning, and multidimensional reduction
and scaling techniques. These techniques were applied to
accomplish two goals: the identiﬁcation of groups of mice and
the identiﬁcation of groups of sickness and depression-like indica-
tors. Widely used methods readily available in commonly used sta-
tistical software and packages are presented and their applicability
to study sickness and depression-like indicators demonstrated.
Unsupervised learning approaches that do not use information
on the BCG treatment received by the mice can revealed the dis-
tinct and complementary information provided by the sickness
and depression-like indicators considered. Supervised learning
approaches that consider the sickness, depression-like and
treatment information can conﬁrm that the identiﬁcation of subtle
differences in behaviors between BCG-treatment groups and
between mice within group.
The workﬂow to analyze multiple behavioral indicators and
gain a comprehensive understanding of the impact of BCG treat-
ment included four stages: (1) characterization of sickness and
depression-like indicators using univariate and multivariate linear
model analyses, (2) discovery of clusters of mice and clusters of
indicators using hierarchical cluster analysis; (3) uncover relation-
ships between mice within and between BCG-treatment groups
and between sickness and depression-like indicators using multi-
dimensional reduction and scaling; and (4) development of mark-
ers to accurately classify mice into BCG-treatment groups using
discriminant analysis and k-nearest neighbor and conﬁrmation of
the classiﬁcation using leave-one-out cross-validation. The algo-
rithms used in this study are widely used and available in multiple
statistical packages and languages including SAS (SAS Institute Inc.,
2013) and R (R Core Team, 2012). The corresponding procedures
available in the previous statistical packages are also noted.3.1. Univariate linear models
Linear models enable the description of the sickness or depres-
sion-like indicators or dependent variables in relationship to a
number of independent variables. Estimates of the relationship
between dependent and independent variables enabled assess-
ment and testing of the strength of these relationships. Body
weight was measured across multiple days within each mouse
and thus a repeated measurement linear mixed effects model
was used to describe the change in body weight across days and
BCG-treatment groups. The model included the ﬁxed effects of
BCG-treatment level (BCG0, BCG5, and BCG10), day (Day 0–5),
the interaction among BCG treatment group and day and body
weight at Day 1. Preliminary tests indicated that the repeated
structure of the measurements was adequately modeled by
an autoregressive order 1 structure including heterogeneity of
variances across days and mouse was the experimental unit.Univariate linear models were used to describe the change in
weight between Day 0 and Day 2, the change in weight between
Day 2 and Day 5, locomotor activity, rearing, immobility in the
forced swim and tail suspension tests, and sucrose preference.
These models included the classiﬁcation ﬁxed effect of BCG-treat-
ment level and the covariate body weight at Day 1. Additional
terms were included in the models of speciﬁc indicators. Models
describing sickness indicators included as covariates depression-
like indicators meanwhile models describing depression-like indi-
cators included as covariates sickness indicators. This strategy
enabled the study of the effect of BCG challenge on sickness or
depression-like indicators adjusted for depression-like or sickness,
respectively. Covariates were nested within BCG-treatment group
to account for the different trends of the covariates within group.
Evaluation of the differences between observed and predicted val-
ues enabled the identiﬁcation of possible outliers and assessment
of departures from the normality assumption. For the sample size
available, the statistical signiﬁcance of parametric tests was con-
ﬁrmed using a non-parametric resampling approach including
10,000 bootstrap samples. Resampling followed PROC MULTEST
and the merBoot method in SAS and R, respectively.
3.2. Multivariate linear models
While univariate models describe one indicator at a time, mul-
tivariate models consider multiple response indicator variables.
Multivariate models are advantageous when the response vari-
ables are correlated through the signal or noise components of
the model. There is a compromise between the gains in precision
to detect the relationship between the indicators and explanatory
variables and the additional parameters in the multivariate relative
to the univariate models (Stearns et al., 2005; Serão et al., 2013). In
a multivariate analysis, the test statistics available to assess the
association between BCG-treatment group and behavioral indica-
tors are equivalent when comparing two groups. Thus, results from
one test, the Roy’s greatest characteristic root are presented. The
multivariate models included the same cofactors and covariates
used in the univariate models. Within the univariate and multivar-
iate analyses, estimable functions were used to compute the
expected behavior indicator value within BCG-treatment group at
the average value of all other covariates. Univariate and multivar-
iate models speciﬁcation followed PROC MIXED and the lme4
package in SAS and R, respectively.
Measurements were inspected for the presence of outliers that
severely deviated from biological or statistical expectations and
could impact the estimates and test statistics. Within linear mod-
els, outliers were identiﬁed using the standardized residuals.
Within unsupervised learning approaches, outliers were identiﬁed
based on the Euclidean distance between pairs of mice based on all
behavioral indicators. Distances were computed using PROC
DISTANCE or the dist function in SAS and R, respectively.
3.3. Cluster analysis
Using the unsupervised learning method of cluster analysis
mice were grouped into clusters of similar behavioral proﬁle. Like-
wise, cluster analysis enabled the grouping of sickness and depres-
sion-like indicators into clusters of similar proﬁle and uncovered
relationship between these indicators. Mice were clustered based
on weight change between Day 0 and Day 2, weight change
between Day 2 and Day 5, locomotor activity, rearing, tail suspen-
sion immobility, forced swim immobility, and sucrose preference.
Also, the behavior indicators were clustered based on information
from all 18 mice across the three BCG-treatment groups. Through
hierarchical agglomerative clustering, mice (or indicators) were
grouped in a sequential manner from lower to higher Euclidean
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items were part of one cluster (Kaufman and Rousseeuw, 2005).
A dendrogram or tree diagram was used to represent the distance
between items (mice or indicators) or between clusters. The
distance between items was represented by the branch length.
The number of clusters supported by the data was inferred from
the changes in the within and across cluster variation along the
clustering process. Routines including PROC CLUSTER and the
hclust function are the SAS and R alternatives, respectively.
3.4. Multi-dimension reduction and scaling approaches
Insights from cluster analysis were complemented with multi-
dimensional approaches that use the information from multiple
orthogonal variables to further understand the relationship
between the behavior indicators. The dimensions reduced or scaled
were the weight change between Day 0 and Day 2, weight change
between Day 2 and Day 5, locomotor activity, rearing, tail suspen-
sion immobility, forced swim immobility and sucrose preference.
Principal component analysis (PCA) and multidimensional scal-
ing (MDS) were used to identify a reduced number of indices (func-
tions of the behavioral indicators measured) that portrayed the
main relationships among mice within and between BGC-treat-
ment groups (Zuur et al., 2007). Each principal component (in
PCA) or scale (in MDS) accounted for a non-overlapping percentage
of the variation of the original behavior indicators in an inverse
relationship between component number and percentage of the
variation explained. In this study, two paths were explored. First,
the correlation between the behavioral indicators was used to infer
the coefﬁcients (or loadings) of these indicators and the relation-
ship between mice. Second, the correlation betweenmice was used
to infer the relationship between the behavioral indicators. The
Pearson’s correlation coefﬁcient between the indicators was
favored over the covariances to level the impact of indicators
despite differences in magnitude.
For dimension reduction purposes, the components or scales
considered were limited to those that explained most and together
accounted for at least 70% of the variance of the original measure-
ments. The relationship between sickness and depression-like
indicators and the relationship between mice within and across
BCG-treatment groups was investigated through the evaluation
of the coefﬁcients of the variables in the ﬁrst principal components
together with the visualization of the relative location of the mice
from different BCG-treatment groups along pairs of major principal
components.
An analysis comparable to PCA was implemented using multidi-
mensional scaling. This approach relied on the distances between
items and double-centering of the distance matrix instead of corre-
lations used in PCA. Thus, the consistency between MDS and PCA
outputs depended on the properties and structure of the original
measurements. Implementation of PCA includes PROC PRINCOMP
and the princomp function in SAS and R, respectively. Implementa-
tion of MDS includes PROC MDS and the cmdscale function in SAS
and R, respectively.
3.5. Supervised learning approaches
Supervised learning approaches that account for the known
BCG-treatment assignment were used to develop decision rules
that assigned mice to classes (i.e. BCG-treatment groups) with
maximum possible accuracy (Zuur et al., 2007). Supervised predic-
tion of mice classiﬁcation into BCG-treatment groups was based on
weight change between Day 0 and Day 2, weight change between
Day 2 and Day 5, locomotor activity, rearing, tail suspension immo-
bility, forced swim immobility and sucrose preference. Consider-
ation of the coefﬁcients of the behavioral indicators in theclassiﬁcation functions offered insights into the relationship
between indicators. Two complementary supervised learning
methods, linear discriminant analysis (LDA) and k-nearest neigh-
bor (KNN), were evaluated. In LDA, the resulting indices of the
behavioral indicators offered the maximum distance between the
observed classes and the minimum variation within class. Mice
were assigned to the class that was most proximal to the LDA index
value. In the KNN approach, mice were assigned to the class of all
or most of the closest neighboring mice based on the Euclidean dis-
tance. The LDA and KNN approaches are implemented in the PROC
CLUSTER and LDA and KNN functions in SAS and R, respectively.
In summary, the linear univariate model analysis was evaluated
because this approach is frequently used in the identiﬁcation of
associations between the variation in behavioral indicators and
BCG treatment. The multivariate model is a statistically well-
understood extension of the univariate approach with comparable
type of outputs. Meanwhile linear models require the identiﬁca-
tion of a response and explanatory variables, unsupervised learn-
ing does not require treatment group information. The results
from PCA and MDS supplement those from cluster analysis. While
cluster analysis identiﬁes groups of variables (mice or behavior
indicators) alike (based on indicators or mice, respectively), PCA
and MDS aid in the identiﬁcation of fewer combinations of the
original variables (mice or behavior indicators) that represent
information comparable to the original variables. Lastly, the
supervised learning approaches LDA and KNN utilize the treatment
information from a number of observations to assign a treatment
group to the remaining observations. The cross-validation imple-
mentation permitted the classiﬁcation of one mouse using a classi-
ﬁer function developed on the remaining mice.4. Results and discussion
A number of approaches were used to further understand the
impact of BCG-challenge on behavior indicators in a mouse model
of inﬂammation-induced depression. This study also investigated
the changes in sickness and depression-like indicators associated
with BCG-treatment levels and mouse-to-mouse variation. Both,
the relationships among mice within a BCG-treatment level and
among behavior indicators were investigated. No mouse was
removed from the analysis because (1) no observation exhibited
an extreme standardized residual in the linear model analyses
and, (2) no extreme Euclidean distances between mice were
detected as part of the unsupervised learning analyses.
For baseline purposes, results from the analysis of individual
behavioral indicators using univariate linear model analyses are
presented ﬁrst. The univariate results served as point of reference
for comparison against results from previous studies and against
results from multivariate linear model analysis and supervised
and unsupervised learning approaches. Additional multivariate
insights on the relationship between mice and between behavior
indicators were gained from cluster, multidimensional reduction
and scaling and discriminant analyses.4.1. Univariate and multivariate linear model analyses of sickness and
depression-like indicators
The testing of differences in behavioral indicators between BCG-
treatment levels using standard univariate models enabled bench-
marking the studied mice population and BCG-challenge against
published studies. Results from the univariate analyses validated
the phenotypic trends reported in related studies (Moreau et al.,
2008; O’Connor et al., 2009). This validation also conﬁrms that
the sample studied is consistent with population expectations.
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Day 0 to Day 5 demonstrated that the signiﬁcant differences in
body weight among the three BCG-treatment groups by Day 2
were no longer signiﬁcant by Day 5 (Fig. 1). The drop in weight
between Day 0 and Day 2 was 0.36 (±0.27), 1.62 (±0.30), and
2.26 (±0.33) for groups BCG0, BCG5 and BCG10, respectively. Prin-
cipal component analysis of daily body weights between Day 0 and
Day 5 uncovered that two major trends (pre and post Day 2)
explained 99% of the variation across the six days. Consideration
of the coefﬁcients in the PCA eigenvectors indicated two body
weight patterns (before and after Day 2) that were consistent with
the linear model ﬁndings. These results are in agreement with pre-
vious reports that BCG-challenged mice lose weight until Day 1 or
Day 2 and subsequently gain weight (Moreau et al., 2008;
O’Connor et al., 2009). Based on these ﬁndings, two weight indica-
tors of sickness were used: weight change between Day 0 and Day
2 and weight change between Day 2 and Day 5. These two mea-
surements were computed as the difference in weight between
the last and the ﬁrst time point. These two measurements captured
the two main weight change trends.
Results from the univariate linear models indicated a signiﬁcant
association between BCG-treatment and both change in weight
between Day 0 and Day 2 (P-value <0.0027) and change in weight
between Day 2 and Day 5 (P-value <0.0046). The models for these
indicators accounted for more than 80% of the variation of weight
(R2 > 80%). Among the BCG-treated mice, the BCG10 group had the
highest (P-value <0.0024) weight loss between Day 0 and Day 2
relative to BCG0 followed by BCG5 (P-value <0.003) meanwhile
the difference in weight change between the BCG10 and BCG5
groups was non-signiﬁcant. Among the BCG-treated mice, the
BCG5 group had the highest (P-value <0.0014) weight gain
between Day 2 and Day 5 relative to BCG0 followed by BCG10
(P-value <0.032) meanwhile the difference in weight change
between the BCG10 and BCG5 groups was non-signiﬁcant.
The multivariate analysis of both weight change indicators
improved the precision, identifying an association between BCGFig. 1. Body weight across days post injection (at Day 0) and across BCG-treatment
measurements longitudinal model. Estimates were adjusted for weight prior to the start o
limits of the estimates.treatment and weight more signiﬁcant (Roy’s greatest Root P-value
<0.0010) than the univariate analyses (P-value <0.0027 and P-value
<0.0046). These results are in agreement with previous studies
using a number of mice strains and genotypes where BCG-chal-
lenged mice exhibited a drop in weight during the ﬁrst 2 days
post-challenge followed by a weight gain (Moreau et al., 2008;
O’Connor et al., 2009; Platt et al., 2013; Painsipp et al., 2013;
Vijaya Kumar et al., 2014). The speed of recovery of body weight
varies with study and strain and meanwhile in some studies body
weight does not differ among BCG-treated and BCG0 mice by Day 6
(Platt et al., 2013; Painsipp et al., 2013), in other studies weight
recovery is detected after Day 7 (Moreau et al., 2008; Kelley
et al., 2013; Vijaya Kumar et al., 2014).
Results from univariate linear models indicated a non-
signiﬁcant (P-value >0.1) association between BCG-treatment and
locomotor activity and rearing. Likewise, the bivariate analysis of
both activity indicators of sickness detected a non-signiﬁcant
BCG treatment effect (Roy’s greatest Root P-value >0.1). These
results are consistent with previous reports that BCG-challenged
mice no longer exhibited signiﬁcant sickness symptoms by Day 6
(Moreau et al., 2008; Platt et al., 2013). Deﬁcits in locomotor activ-
ity in BCG-induced mice were nearly resolved by Day 1 and were
non-signiﬁcant by Day 7 (Platt et al., 2013; Kelley et al., 2013).
One study reported borderline non-signiﬁcant differences in loco-
motor activity by Day 7 in C57BL/6N mice (Painsipp et al., 2013)
meanwhile a different study using C57BL/6J mice reported
non-signiﬁcant differences in rearing yet signiﬁcant differences in
horizontal locomotor activity after Day 7 (O’Connor et al., 2009).
Another study using BALB/c mice found non-signiﬁcant differences
in total distance traveled by Day 14 post-challenge, although dif-
ferences were still signiﬁcant by Day 7 (Vijaya Kumar et al., 2014).
The results from the univariate linear model analysis indicated
a signiﬁcant (P-value <0.0336; R2 = 71%) BCG-treatment effect on
tail suspension immobility. In particular, a signiﬁcant (P-value
<0.0363) difference in mobility between BCG-treated and non-
treated groups was detected. These results are consistent withlevel [BCG0 (n = 7), BCG5 (n = 6), and BCG10 (n = 5)] estimated from a repeated-
f the experiment and for heterogeneity of variance. Whiskers denote 95% conﬁdence
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persisted beyond sickness behaviors after Day 7 (Moreau et al.,
2008; O’Connor et al., 2009; Platt et al., 2013; Kelley et al., 2013;
Vijaya Kumar et al., 2014). A borderline signiﬁcant (P-value
>0.09; R2 = 59%) difference between BCG-treated and non-treated
mice groups was detected for forced swim immobility. Mice in
the BCG0 group remained immobile less time than BCG-treated
mice and the immobility of BCG5 mice was closer to BCG10 than
to BCG0 mice. The trends for sucrose preference followed a similar
pattern albeit non-signiﬁcant (P-value >0.1). Mice in the BCG0
group exhibited higher sucrose consumption than BCG-treated
mice and the sucrose consumption by the BCG5 mice was closer
to BCG10 than to BCG0 mice. These ﬁndings are consistent with
a previous report of non-signiﬁcant differences in forced swim
and sucrose preference indicators between BCG-treated and saline
groups (Moreau et al., 2008). Similar to weight change, the applica-
tion of multivariate analyses to the three depression-like indicators
demonstrated the potential of this approach for to account for the
correlation between indicators and to augment the analytical pre-
cision. A signiﬁcant effect of BCG-treatment group on all three
depression-like indicators and a signiﬁcant difference between
BCG-treated and non-treated groups was detected (Roy’s greatest
Root P-value <0.036). This association was identiﬁed despite the
higher number of estimated parameters in the multivariate analy-
sis compared to the univariate analyses and despite that the uni-
variate analysis detected a non-signiﬁcant association. Signiﬁcant
differences in the forced swim and tail suspension immobility
between BCG-treated and saline-treated mice beyond Day 7 have
been reported (O’Connor et al., 2009).
The visualization of the distribution of mice within and across
BCG-treatment groups resulting from the cluster, principal compo-
nent, and discriminant analyses revealed distinct behavioral
patterns between mice in the BCG10 and BCG5 groups and also
mouse-to-mouse variation within group. The multidimensionalFig. 2. Dendrogram displaying the distance (branch length measured in semi-partial R2 u
leftmost vertical axis label denoting the BCG-treatment group [10 = BCG10 (n = 5), 5 = B
number.approaches demonstrated the distinct and complementary nature
of sickness and depression-like indicators. These analyses also con-
ﬁrmed the behavioral differences between BCG-treated and non-
treated mice. Multivariate unsupervised and supervised methods
were used to identify both, groups of mice with similar behaviors
and groups of behavioral indicators that exhibited similar proﬁles
across mice.
4.2. Unsupervised learning analysis
Hierarchical cluster analysis was explored because this
approach does not require the assumption of speciﬁc parameters
describing the relationship between the variables considered. The
dendrogram resulting from the hierarchical cluster analysis of mice
is presented in Fig. 2. The shorter the branch length of a dendro-
gram, the shorter the distance (the greater the similarity) between
mice across the seven behavior indicators considered. The branch
length was quantiﬁed using the semi-partial R2 that measures
the increase in variability within cluster (relative to between clus-
ters) resulting from the grouping of mice, partial on the number of
clusters in each dendrogram level. The longest branches connected
the three BCG treatment groups. Furthermore, mice from BCG0
group were more distant from the other groups relative to the dis-
tance between BCG5 and BCG10 mice. All except two mice were
proximal to mice within the same BCG treatment group. The
exceptions include one BCG5 mouse that was closer to a BCG10
mouse and one BCG10 mouse (mouse number 22) that was closer
to a BCG0 mouse than to mice from their corresponding treatment
groups. Results from complementary MDS analysis of the BCG10
mouse number 22 are presented in the MDS section.
A previous study reported substantial mouse-to-mouse varia-
tion in the depression-like indicator immobility among CD-1 mice
treated with BCG (Platt et al., 2013). In that study, up to 30% of
BCG-treated mice did not exhibit increased immobility in the tailnits) between mice across BCG treatment groups. Mouse identiﬁcation includes the
CG5 (n = 6), or 0 = BCG0, (n = 7)] followed by ‘‘_’’ and the mouse unique identiﬁer
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egorized as ‘‘resilient’’ to BCG induced behavioral changes. The
majority of BCG-treated mice exhibited increased immobility at
Day 6 post treatment and were categorized as ‘‘susceptible’’.
Further understanding of the relationship between behavioral
indicators was gained from complementary disjoint cluster analy-
sis using a divisive process. The dendrogram in Fig. 3 depicts the
relationship between indicators. The branch length or indicator
of distance represents the proportion of the variance explained
by the clustered indicators. As demonstrated in the dendrogram,
the more distant the indicators being clustered (e.g. clustering of
depression-like and sickness indicators relative to the clustering
of two sickness indicators), the lower the proportion of the
variance explained by the clusters. The disjoint procedure clearly
demonstrates the complementary information offered by the
sickness and depression-like indicators. The weight-change sickness
indicators were clustered together and in proximity to the
other sickness indicators, locomotor activity and rearing. The
depression-like indicators were distant from all sickness
indicators, and among these, the immobility indicators were more
proximal to each other than to sucrose preference.
4.3. Principal component analysis and multidimensional scaling
The dendrogram from hierarchical cluster analysis constituted
the ﬁrst step towards understanding the relationship between
mice, treatment groups and behavioral indicators. However, the
collapse of the distance information into one number (the branch
length connecting the item or cluster to other clusters) may limit
the understanding of the contributions of individual mouse or
indicators to the relative distance between items and clusters.Fig. 3. Dendrogram displaying the distance (branch length measured in proportion of va
Day 0 and 2 (W20), change in weight between Day 2 and 5 (W52), horizontal locomotor a
in the tail suspension test (TST), immobility in the forced swim test (FST) and sucrose pFor example, the position of a mouse in the dendrogram may be
the result of consistent patterns across all behavioral indicators
or may be the result of an average across distinct patterns.
Dimensional reduction and scaling approaches were considered
to expand the understanding of the role of sickness and
depression-like indicators on BCG-treatment grouping and of the
role of mice from different BCG-treatment groups in the grouping
of behavioral indicators.
The interpretation of the multivariate information from all
seven sickness and depression-like indicators across mice and
BCG-treatment groups was enhanced by the three main outcomes
from PCA: (a) the number of principal components that account for
the majority of the variation of the original measurements; (b) the
coefﬁcients of the variables in the major principal components;
and (c) visualization of the distribution of the items along the
major principal components.
The plot of the ﬁrst three principal components depicts the clear
separation between mice in the BCG0 group, denoted by circles,
and the other two BCG-treated groups (Fig. 4). The ﬁrst three prin-
cipal components of the PCA used to identify the distribution of
mice across the most informative and orthogonal dimensions,
explained 70% of the variation of the seven original behavioral
indicators. Meanwhile principal component 1 enabled the separa-
tion between BCG0 and BCG-treated mice, principal components 2
and 3 enabled the separation between BCG10 and 5 groups. As
expected, the weaker differences in behavioral indicators between
the two BCG-treated groups required additional principal compo-
nents to distinguish the groups.
The coefﬁcients of the original behavioral indicators in the ﬁrst
three principal components conﬁrmed the distinct patterns pro-
ﬁled by the sickness indicators. Fig. 5 depicts the coefﬁcients ofriance explained) between sickness indicators including change in weight between
ctivity (LMA) and rearing (REA), and depression-like indicators including immobility
reference test (SPT) based on n = 18 mice.
Fig. 4. Distribution of the mice in the BCG10 (red squares, n = 5), BCG5 (orange diamonds, n = 6) and BCG0 (green circles, n = 7) across the ﬁrst three principal components
(Prin1, Prin2, Prin3). (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of this article.)
Fig. 5. Coefﬁcients (or loadings) received by each sickness and depression-like indicator (based on n = 18 mice) in the ﬁrst three principal components (PC1, PC2, and PC3).
Small circle: weight change between Day 0 and 2; large circle: weight change between Day 2 and 5; small square: horizontal locomotor activity; large square: rearing; small
diamond: tail suspension immobility; medium diamond: forced swim immobility; and large diamond: sucrose preference.
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Similar coefﬁcient values within a principal component indicate
that the behavioral indicators exhibited a similar covariation. The
sickness indicators (change in weight between Day 0 and 2, change
in weight between Day 2 and 5, locomotor activity and rearing)
received the most extreme coefﬁcients in principal component 1.The nearly opposite coefﬁcients of both weight changes correspond
to the opposite patterns of weight change prior and post Day 2 in
BCG-treated mice. On the other hand, the similar coefﬁcients
received by the horizontal locomotor activity and rearing are con-
sistent with the similar impact of BCG-treatment on both activity
indicators at Day 6. The coefﬁcients in principal components 2
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sion-like indicators of immobility.
The results from PCA supplement those from cluster analysis
because meanwhile cluster analysis identiﬁes groups of variables
(mice or behavioral indicators) alike (based on indicators or mice,
respectively), PCA is a process for identifying combination of the
original variables (mice or behavioral indicators) that represent
information comparable to the original variables. The outcome
from cluster analysis is the grouping of the original variables based
on a criterion (e.g. variation between versus within clusters) mean-
while the outcomes from PCA are linear indices of the original vari-
ables. The coefﬁcients of the variables in the indices offer insights
into the relationship between the original variables and this
information is expected to be consistent or complementary to
the relationships identiﬁed in the cluster analysis.
The PCA coefﬁcients received by the behavioral indicators
depicted in Fig. 5 are consistent with the clustering of indicators
presented in Fig. 3. The pair of indicators locomotor activity and
rearing and the pair of indicators tail suspension test and sucrose
preference test appear closer to each other. The three dimensions
of the PCA reported offer additional information to the one dimen-
sion of the lengths of the cluster tree branches. For example, mean-
while the weight change between Day 0 and Day 2 and the weight
change between Day 2 and Day 5 received coefﬁcients of similar
magnitude for principal components 1 and 3, the magnitudes differ
for principal component 2. Another complementary insight from
the consideration of three principal components relative to cluster
analysis is the characterization of the relationship between the
three depression-like indicators. Sucrose preference received coef-
ﬁcients of similar magnitude to tail suspension and forced swim
immobility for principal components 1 and 2 and different for prin-
cipal component 3. This evaluation of the changes in the relation-
ship between the coefﬁcients across principal components further
conﬁrms the supplementary information provided by the three
dimensions considered.4.4. Multidimensional scaling
Multidimensional scaling is a class of method to map items and
under speciﬁc circumstances, produces the same output as PCA.
The complementary and conﬁrmatory insights offered by MDS
were evaluated. Results from MDS of the relationship between
indicators conﬁrmed the closer relationship within sickness and
within depression-like indicators (Fig. 6 left). Dimension 2
differentiated between sickness indicators (receiving positiveFig. 6. Left: Distribution of the behavioral indicators across multidimensional scaling di
[_0 = BCG0 (n = 7), _5 = BCG5 (n = 6), _10 = BCG10 (n = 5)] followed by ‘‘_’’ and by the mcoefﬁcients) and depression-like indicators (receiving negative
coefﬁcients). Dimension 1 differentiated among the sickness indi-
cators weight change (receiving positive coefﬁcients) and activity
(receiving negative coefﬁcients).
The overall consistency of results between the PCA and MDS
analyses speaks to the strength of the relationships among the
behavioral indicators measured in this study. The slight differences
between the relative coefﬁcients in the PCA and MDS implementa-
tions is related to the PCA identiﬁcation of the linear combination
of indicators that maximize the explained variance adjusted for all
higher order combinations, meanwhile MDS preserved the dis-
tances between items while representing the items in a lower
dimensional space.
The results fromMDS conﬁrmed the distribution of mice within
and between BCG-treatment groups observed in the PCA (Fig. 6
right). Mice from the BCG0 and BCG10 groups were located on
either side of the two-dimensional plot, meanwhile mice in the
BCG5 group were located in-between. Multidimensional scaling
analysis offered insights into the relative behavior of BCG10 mouse
number 22 that clustered closer to the BCG0 group. Fig. 6 (right)
demonstrates that this mouse was approximately half-way in
between group BCG10 and BCG0. Closer inspection of the indica-
tors revealed that despite exhibiting levels of horizontal locomotor
activity, rearing, forced swim immobility, and sucrose preference
consistent with other mice in the BCG10 group, this mouse main-
tained weight during the trial. The unique combination of levels
displayed by this mouse suggests the need to consider multiple
sickness and depression-like indicators simultaneously and the
need to measure additional mice.4.5. Linear discriminant analysis
Linear discriminant analysis enabled a perfect discrimination of
the mice among the corresponding BCG-treatment groups without
miss-assignments. Leave-one-out cross validation conﬁrmed these
BCG-treatment class assignments. The coefﬁcients of the behav-
ioral indicators in the indices that discriminate between BCG10,
BCG5 and BCG0 offered insights into the impact of indicators in
the discrimination between BCG-treated and BCG0 but also within
BCG-treated groups (Table 1). A linear trend was observed between
the coefﬁcient of the indicator and the BCG-treatment level in all
except two behavior indicators. The linear trend consists on an
increase (or decrease) in the coefﬁcient with BCG-treatment level.
This trend slightly departed for the forced swim immobility; how-
ever, the difference in coefﬁcients between BCG-treatment levelsmensions 1 and 2. Right: Distribution of mice denoted by the BCG-treatment group
ouse identiﬁer number from multidimensional scaling dimensions 1 and 3.
Table 1
Coefﬁcients of sickness and depression-like indicators in the discriminant indices that
assigned mice to the BCG0, BCG5 and BCG10 groups based on n = 18 mice.
Behavior indicator BCG0 BCG5 BCG10
Change in weight between Day 0 and 2 2.22750 3.22502 3.73052
Change in weight between Day 2 and 5 1.72475 7.78472 3.25526
Horizontal locomotor activity 0.88061 1.10627 0.77754
Rearing 4.04187 3.82697 3.36034
Forced swim immobility 0.38761 0.28640 0.31652
Tail suspension immobility 0.14464 0.05314 0.01539
Sucrose preference 1.89954 1.66150 1.63912
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and 5 and locomotor activity, the BCG5 group exhibited a substan-
tially more extreme coefﬁcient than the other two groups. These
results suggest that the differences between both BCG-treated
groups were driven by difference in sickness indicators, and in par-
ticular the capability to recover lost weight and to display horizon-
tal locomotor activity. The difference between BCG-treatment
groups in weight change was detected in the univariate analysis
meanwhile the difference in horizontal locomotor activity was
highlighted by linear discriminant analysis. These results conﬁrm
the additional insight offered by complementary approaches.
Furthermore, mouse number 22 pertaining to group BCG10 was
classiﬁed in the correct group. The tail suspension test measure-
ment of mouse number 22 was the lowest of the group; however
the value was not distant from the second lowest measurement.
4.6. K-nearest neighbor method
Using the nearest neighbor mouse and the seven sickness and
depression-like indicators, all mice were correctly assigned to the
correct BCG-treatment group. Using the information on all seven
sickness and depression-like indicators from the two most proxi-
mal neighbor mice, all BCG0 mice and all BCG10 mice were dis-
criminated into the corresponding groups. Among the BCG5
group, four mice were assigned to the correct group and two mice
were assigned to the BCG10 group. This result speaks to the
mouse-to-mouse variability within BCG-treatment group and
the between within group variation. The two miss-classiﬁed
BCG5 mice exhibited proﬁles similar to BCG10 mice. This result
supports previous reports of varying levels of susceptibility of mice
to BCG-challenge
4.7. Additional considerations
Laboratory effects on behavioral indicators including apparatus,
test procedure, order of tests, and experimenter error have been
widely recognized (Chesler et al., 2002a,b; Brown, 2007). Behaviors
measured by a number of tests appear to be more sensitive to the
previous testing experience than others (McIlwain et al., 2001).
Alternative tests to measure sickness and depression-like indica-
tors could offer complementary information on the association
between BCG-treatment and behavior. Supporting this, multivari-
ate approaches are well suited to handle additional behavioral
indicators. However, care must be exercised to ensure that the
order of a larger number of tests on the same subjects does not
inﬂuence the measurements. Also, consideration of multiple
mouse strains would enable the testing of synergistic or antagonis-
tic relationships between strain and BCG-treatment on behavioral
indicators in addition to the detection of treatment effects that are
common to all strains. Recommendations for supervised and unsu-
pervised analyses include the availability of at least ﬁve observa-
tions per variable (Stevens, 2009). In this study the multivariate
linear model described two (weight changes or locomotor activityand rearing) or three variables (tail suspension test, forced-
swimming test, and sucrose preference test). For these analyses,
the 18 subjects available were adequate. The availability of more
observations would augment the precision of the estimates and
enable independent cross-validation.
5. Conclusions
Reductionistic and modular analysis of individual behavioral
indicators may fail to capture trends that can become evident
when multiple modules are considered simultaneously. This study
compared the results from reductionistic and systemic multivari-
ate or multidimensional approaches to understand the changes
in behavioral indicators associated with infection status. Four sick-
ness indicators and three depression-like indicators were mea-
sured in mice receiving either one of three BCG-treatment levels.
Mice treated with BCG exhibited sickness as indicated by changes
in body weight during the ﬁrst days after the challenge. Although
the difference in sickness indicators between BCG-treatment
groups subsided by Day 5, differences in depression-like indicators
were detected in subsequent days. The previous trends were
weaker or less recognizable in the univariate reductionist analysis
than in the multivariate systemic analysis. Our results showed that
the classical univariate analysis of indicators individually may fail
to capture borderline trends. This ﬁnding is important because
detecting subtle differences between treatment groups or subjects
within treatment group is becoming more critical with the recog-
nition of the effectiveness of individualized therapies. Further-
more, the multivariate and multidimensional approaches offered
information on the relationship between behavioral indicators
and between mice within and across treatment groups, in addition
to traditional test statistics.
Cluster, multidimensional reduction and scaling analyses fur-
ther characterized the interplay between sickness and depres-
sion-like indicators. The distribution of mice across sickness and
depression-like dimensions conﬁrmed that the BCG5 treatment
elicited weaker changes in sickness and depression-like indicators
than the BCG10 treatment. Also, the distribution of mice within
BCG-treatment group conﬁrmed mouse-to-mouse variation on
the susceptibility to challenge across the multiple behavior indica-
tors. This result suggests that studies aimed at characterizing
mouse-to-mouse variation may consider low BCG dose levels.
Subject-to-subject variation in behavioral response to infection
and identiﬁcation of differential susceptibility has been reported in
humans (Walker et al., 2011). Beyond the polygenic nature of sus-
ceptibility to BCG challenge, results from the multivariate analysis
suggested an epistatic mode of action of some genes across indica-
tors. The impact of indoleamine 2,3-dioxygenase on the develop-
ment of BCG-induced behavioral changes has been demonstrated
(O’Connor et al., 2009). Resistance-associated macrophage protein
1, and interferon regulator factor 8 (IRF8) are among other genes
associated with variation in the susceptibility to BCG infection
(Fortin et al., 2007). Structural variation in these genes together
with regulatory variation in the HPA axis activity are expected to
inﬂuence inﬂammation-related sickness and depression-like
behaviors. Future multivariate studies of sickness and depres-
sion-like behaviors in BCG-challenged mice will beneﬁt from con-
sideration of the concentrations of circulating pro-inﬂammatory
cytokines and immune activation together with genomic sequence
variation among mice.
The capability of multivariate models to enhance the precision
to detect differences among BCG-treatment groups relative to uni-
variate models was demonstrated both for weight changes indica-
tors of sickness and for the three depression-like indicators. The
unsupervised learning approaches demonstrated the distinct
characterization provided by the sickness and depression-like
186 S.L. Rodriguez-Zas et al. / Brain, Behavior, and Immunity 44 (2015) 176–186indicators studied. This complementarity was conﬁrmed by the
supervised learning approaches. Therefore, multivariate analysis
is recommended to establish models that enable understanding
of complex interactions between various types of response to
infection.
Acknowledgments
The support of NIH grant numbers: R21 MH 096030, R01 MH
090127, R01 SUB UT 00000712, R01 MH083767, and USDA NIFA
grant number 2012-38420-30209 are greatly appreciated.
References
Brown, R., 2007. Behavioural phenotyping of transgenic mice. Can. J. Exp. Psychol.
61 (4), 328–344. http://dx.doi.org/10.1037/cjep2007033.
Brown, R., Corey, S., Moore, A., 1999. Differences in measures of exploration and fear
in MHC-congenic C57BL/6J and B6-H-2K mice. Behav. Genet. 29 (4), 263–271.
http://dx.doi.org/10.1023/A:1021694307672.
Brydon, L., Harrison, N.A., Walker, C., Steptoe, A., Critchley, H.D., 2008. Peripheral
inﬂammation is associated with altered substantia nigra activity and
psychomotor slowing in humans. Biol. Psychiatry 63 (11), 1022–1029. http://
dx.doi.org/10.1016/j.biopsych.2007.12.007.
Capuron, L., Miller, A.H., 2011. Immune system to brain signaling:
neuropsychopharmacological implications. Pharmacol. Ther. 130 (2),
226–238. http://dx.doi.org/10.1016/j.jad.2004.04.002.
Castagné, V., Moser, P., Roux, S., Porsolt, R.D., 2011. Rodent models of depression:
forced swim and tail suspension behavioral despair tests in rats and mice. Curr.
Protoc. Neurosci. 8 (8.10A), 1–14. http://dx.doi.org/10.1002/0471142301.
ns0810as55.
Chesler, E.J., Wilson, S.G., Lariviere, W.R., Rodriguez-Zas, S.L., Mogil, J.S., 2002a.
Inﬂuences of laboratory environment on behavior. Nat. Neurosci. 5 (11), 1101–
1102. http://dx.doi.org/10.1038/nn1102-1101.
Chesler, E.J., Wilson, S.G., Lariviere, W.R., Rodriguez-Zas, S.L., Mogil, J.S., 2002b.
Identiﬁcation and ranking of genetic and laboratory environment factors
inﬂuencing a behavioral trait, thermal nociception, via computational analysis
of a large data archive. Neurosci. Biobehav. Rev. 26 (8), 907–923. http://
dx.doi.org/10.1016/S0149-7634(02)00103-3.
Fortin, A., Abel, L., Casanova, J.L., Gros, P., 2007. Host genetics of mycobacterial
diseases in mice and men: forward genetic studies of BCG-osis and tuberculosis.
Annu. Rev. Genomics Hum. Genet. 8 (1), 163–192. http://dx.doi.org/10.1146/
annurev.genom.8.080706.092315.
Kaufman, L., Rouseseeuw, P.J., 2005. Finding Groups in Data: An Introduction to
Cluster Analysis. Wiley Series in Probability and Statistics. John Wiley & Sons,
Inc., Hoboken, New Jersey, ISBN 0-417-73578-7.
Kelley, K.W., O’Connor, J.C., Lawson, M.A., Dantzer, R., Rodriguez-Zas, S.L., McCusker,
R.H., 2013. Aging leads to prolonged duration of inﬂammation-induced
depression-like behavior caused by Bacillus Calmette-Guérin. Brain Behav.
Immun. 32, 63–69. http://dx.doi.org/10.1016/j.bbi.2013.02.003.
Lawson, M.A., Parrott, J.M., McCusker, R.H., Dantzer, R., Kelley, K.W., O’Connor, J.C.,
2013. Intracerebroventricular administration of lipopolysaccharide induces
indoleamine-2,3-dioxygenase-dependent depression-like behaviors. J.
Neuroinﬂamm. 10, 87. http://dx.doi.org/10.1186/1742-2094-10-87.Maes, M., 2011. Depression is an inﬂammatory disease, but cell-mediated immune
activation is the key component of depression. Prog. Neuropsychopharmacol.
Biol. Psychiatry Neuroinﬂamm. Neuroprog. Pathways Depress. 35 (3), 664–675.
http://dx.doi.org/10.1016/j.pnpbp.2010.06.014.
McIlwain, K.L., Merriweather, M.Y., Yuva-Paylor, L.A., Paylor, R., 2001. The use of
behavioral test batteries: effects of training history. Physiol. Behav. 73 (5), 705–
717. http://dx.doi.org/10.1016/S0031-9384(01)00528-5.
Moreau, M., André, C., O’Connor, J.C., Dumich, S.A., Woods, J.A., Kelley, K.W., Dantzer,
R., Lestage, J., Castanon, N., 2008. Inoculation of Bacillus Calmette-Guerin to
mice induces an acute episode of sickness behavior followed by chronic
depressive-like behavior. Brain Behav. Immun. 22 (7), 1087–1095. http://
dx.doi.org/10.1016/j.bbi.2008.04.001.
O’Connor, J.C., André, C., Wang, Y., Lawson, M.A., Szegedi, S.S., Lestage, J., Castanon,
N., Kelley, K.W., Dantzer, R., 2009. Interferon-c and tumor necrosis factor-a
mediate the upregulation of indoleamine 2,3-dioxygenase and the induction of
depressive-like behavior in mice in response to Bacillus Calmette-Guérin. J.
Neurosci. 29 (13), 4200–4209. http://dx.doi.org/10.1523/JNEUROSCI.5032-
08.2009.
Painsipp, E., Köfer, M.J., Farzi, A., Dischinger, U.S., Sinner, F., Herzog, H., Holzer, P.,
2013. Neuropeptide Y and peptide YY protect fromweight loss caused by Bacille
Calmette-Guérin in mice. Br. J. Pharmacol. 170 (5), 1014–1026. http://
dx.doi.org/10.1111/bph.12354.
Platt, B., Schulenberg, J., Klee, N., Nizami, M., Clark, J., 2013. A depressive phenotype
induced by Bacille Calmette Guérin in ‘susceptible’ animals: sensitivity to
antidepressants. Psychopharmacology 226 (3), 501–513. http://dx.doi.org/
10.1007/s00213-012-2923-6.
R Core Team, 2012. R: A Language and Environment for Statistical Computing. R
Foundation for Statistical Computing, Vienna, Austria, <http://www.R-
project.org/>.
SAS Institute Inc, 2013. SAS/STAT 13.1 User’s Guide. SAS Institute Inc., Cary, NC.
Serão, N.V.L., González-Peña, D., Beever, J.E., Bollero, G.A., Southey, B.R., Faulkner,
D.B., Rodriguez-Zas, S.L., 2013. Bivariate genome-wide association analysis of
the growth and intake components of feed efﬁciency. PLoS ONE 8 (10), e78530.
http://dx.doi.org/10.1371/journal.pone.0078530.
Stearns, T.M., Beever, J.E., Southey, B.R., Ellis, M., McKeith, F.K., Rodriguez-Zas, S.L.,
2005. Evaluation of approaches to detect quantitative trait loci for growth,
carcass, and meat quality on swine chromosomes 2, 6, 13, and 18. II.
Multivariate and principal component analyses. J. Anim. Sci. 83 (11),
2471–2481.
Stevens, J.P., 2009. Applied Multivariate Statistics for the Social Sciences, ﬁfth ed.
Routledge, Taylor & Francis Group, New York, NY.
Strekalova, T., Couch, Y., Kholod, N., Boyks, M., Malin, D., Leprince, P., Steinbusch,
H.M., 2011. Update in the methodology of the chronic stress paradigm: internal
control matters. Behav. Brain Funct. 7, 9. http://dx.doi.org/10.1186/1744-9081-
7-9.
Vijaya, Kumar K., Rudra, A., Sreedhara, M.V., Siva Subramani, T., Prasad, D.S., Das,
M.L., Murugesan, S., Yadav, R., Trivedi, R.K., Louis, J.V., Li, Y.W., Bristow, L.J.,
Naidu, P.S., Vikramadithyan, R.K., 2014. Bacillus Calmette-Guerin vaccine
induces a selective serotonin reuptake inhibitor (SSRI)-resistant depression
like phenotype in mice. Brain Behav. Immun. 42, 204–211.
Walker, J.R., Graff, L.A., Dutz, J.P., Bernstein, C.N., 2011. Psychiatric disorders in
patients with immune-mediated inﬂammatory diseases: prevalence,
association with disease activity, and overall patient well-being. J. Rheumatol.
Suppl. 88, 31–35. http://dx.doi.org/10.3899/jrheum.110900.
Zuur, A.F., Ieno, E.N., Smith, G.M., 2007. Analysing Ecological Data. Springer, New
York.
